Viridian Therapeutics Inc — Quarterly Financial Statistics (NASDAQ:VRDN) | MetaTrader

Open full chart

Financials

Overview Estratto Conto Statistics Dividends

Quarterly Annual

Cash from operating activities -67.71 M-73.33 M-92.65 M-75.37 M-84.61 M23.75 M -228.88 M Cash from investing activities -84.67 M-62.91 M100.06 M75.72 M126.08 M-264.29 M 37.56 M Cash from financing activities 245.02 M35.52 M9.21 M764 K10.86 M405.91 M 426.74 M Free cash flow -68 M-73.45 M-92.74 M-75.42 M-84.74 M23.51 M -229.38 M

Notizie

Stifel conferma il rating su Viridian Therapeutics per revisione BLA

Stifel reiterates Viridian Therapeutic stock rating on BLA review

Jefferies alza il target di prezzo di Viridian Therapeutic per i progressi negli studi clinici

Jefferies raises Viridian Therapeutic stock price target on trial progress

Evercore ISI conferma il rating su Viridian Therapeutics per fiducia nei dati

Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction

Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates

Gli EPS di Viridian Therapeutics hanno mancato le aspettative per 0,10$, il fatturato appena sotto le previsioni

Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates

MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates

BB Biotech FY 2025: utili +660%, outlook 2026 cauto

Truist conferma il rating su Viridian Therapeutics prima dei trial